Navigation Links
Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine
Date:9/10/2008

MEMPHIS, Tenn., Sept. 10 /PRNewswire/ -- As a surgeon and clinical instructor, Dr. Jeffery Deal, MD, FACS, DTMH, knew firsthand about the growing number of patients contracting ... and dying from ... Hospital Acquired Infections. He was also keenly aware that infections are quickly spreading beyond the healthcare system into schools, gyms, prisons and retirement homes.

A 2004 study supervised by Dr. Deal tracked 13,510 admissions at an accredited 450-bed regional hospital. Almost fifteen percent, 2,012 patients, acquired an infection. The average length of stay for infected patients increased 9.25 days, and direct hospital costs increased $13,118,000 -- over $29,000 per bed per year.

The CDC concedes that over two million people in the US will acquire an infection while in a hospital this year, and that more than 100,000 infected patients will die as a result. That's more deaths than are caused by murder, breast cancer and AIDS ... combined.

As infection rates continue to climb, industry experts predict a rash of lawsuits. "The common belief that 'infections are unavoidable' has shielded hospitals and doctors from liability for decades. But not in the future," states Dr. Betsy McCaughy, author of "Unnecessary Deaths: The Human and Financial Costs of Hospital Infections," 3rd edition.

Dr. Deal knew that reducing the biological pool of pathogens would reduce hospital infection. "Our goal was to find a disinfection method that was fast, safe and thorough; used no chemicals; and was automated to eliminate human error and reduce costs." After years of clinical trials, Dr. Deal applied for the first of two patents for the TRU-D Total Room Ultraviolet Disinfector. "Our research team developed a fail-safe disinfection method using germ-lethal doses of reflected UV germicidal energy to destroy virus, bacteria and spores within both line-of-site and primary shadow behind bed rails, door knobs and IV poles. TRU-D disinfected every pathogen on
'/>"/>

SOURCE Lumalier Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
2. The ED Conversation Dilemma: Forty Percent of Men with ED Dont Talk to Their Doctor, Survey Finds
3. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
4. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
5. Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate
6. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
7. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
8. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
9. Nations Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections
10. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
11. Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 4BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 1National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 2National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 3
...7 Trius Therapeutics, Inc. announced,today that i...-701, an,antibacterial drug candidate intended for...bacterial infections, including those caused by MR...ght subject single and,multiple ascending dose tri...tics of the oral dosage form of the drug and will ...
...uided Nanoparticles May Deliver Treatments to Huma... used,magnetic fields and tiny iron-bearing partic...ood vessels. The research, done in animals, may le...o repair injured or diseased,organs in people., (...07/DC10966 ), The study team, led by Robert J. L...
Other Medicine Technology:Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701 2Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4
(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...CalgaryScientificInc.,aleadingproviderofsoftwareen...s(TM)Breast4DAdvancedVisualizationsoftware. ,, ...ntWebclientbasedmedicalimagingofferinginthemarket....o-footprintaccess-requiringnosoftwaredownload,andr...
(Date:11/25/2009)...swire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,d...h,titled"ADifficultBalance-PainManagement,DrugSafe...EnglandJournalofMedicine. ,, (Logo: http://www....Inthearticle,WoodcockdiscussesFDAeffortstostrikeab...itandmanagingtherisksposedbyvariousanalgesics.Asex...
(Date:11/25/2009)...usiness,andPressJoinEfforttoEducate ,, MEMPHIS...eNationalBipolarFoundationandtheMedicAlertFoundati...e"program,whichisnowbeingwidelyacceptedasapreventi...ionalBipolarFoundationreceivedaproclamationofendor...norofLouisianaMitchLandrieu.TheNationalBipolarFoun...
(Date:11/25/2009)...out of a collaboration between UCLA engineers and ...rly 10 million Americans who suffer from periphera...g of the arteries, peripheral arterial disease, or...rowed arteries reduce blood flow to the limbs. The...isease, heart attack and stroke, and its progressi...
(Date:11/25/2009)...matoid arthritis, could help newly diagnosed diabe... (HealthDay News) -- A drug commonly used to treat...ow also shows some promise in helping patients new...rituximab (Rituxan), helped patients keep producin...se had destroyed some of their pancreatic beta cel...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ormation is Meaningful,and in Appropriate Context,...logy Association (AdvaMed) today expressed support...ionships with physicians by,putting forth key chan...ed innovation in medical technology relies on dire...
...inating against a variety of infectious diseases ...ther than needles has proved able to produce a st...wo new studies. , The results build on previous s...ines developed at the Michigan Nanotechnology Inst...
...in Florida and Texas, JACKSONVILLE, Fla. and BETH...TM) today announced an agreement to equip physicia...ing service under,Availity,s private label, CarePr...g of Blue Cross and Blue Shield of,Florida, Humana...
...6-month study , , TUESDAY, Feb. 26 (Healt...ins the antiretroviral drug tenofovir is safe for ...a six-month study of 200 women in India and the Un...le to adhere to a regimen of either daily or sex-d...
...nd Fund Health Needs, WASHINGTON, Feb. 26 A coal...a newspaper and radio advertising,campaign in supp...ky,s,cigarette tax by 70 cents per pack, reduce sm... Kentucky lawmakers to support House Bill,443, spo...
...s, Inc. (Nasdaq: ADLS ), a biopharmaceutical comp...ercialization of novel drugs in the,therapeutic ar... today,announced that it will present at Susquehan...cgi-bin/prnh/20080218/ALSLOGO ), Advanced Life Sc...
Other Medicine News:Health News:AdvaMed Supports Key Changes to Disclosure Legislation 2Health News:AdvaMed Supports Key Changes to Disclosure Legislation 3Health News:Nanoemulsion vaccines show increasing promise 2Health News:Nanoemulsion vaccines show increasing promise 3Health News:Nanoemulsion vaccines show increasing promise 4Health News:Availity Engages Prematics to Deploy Electronic Prescribing 2Health News:Availity Engages Prematics to Deploy Electronic Prescribing 3Health News:HIV Drug in Microbicide Gel Safe for Daily Use 2Health News:Health Groups Launch Ad Campaign Supporting 70-Cent Increase in Kentucky Cigarette Tax 2Health News:Advanced Life Sciences to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference 2
...y that a second mirror adds, then you may want to ...same 1.5x magnification as the G-1 but offers two ... Available in standard (flange) or new glass NF (n...anged" model for laser use. Provides broader vie...
Direct Image AFX SSV®
Direct Image High-Mag SSV®
Direct Image Mid Field
Medicine Products: